Condensed Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders' Equity (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total		Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income
Temporary equity, beginning balance (in shares) at Dec. 31, 2023	432
Temporary equity, beginning balance at Dec. 31, 2023	$ 351,260
Increase (Decrease) in Temporary Equity [Roll Forward]
Preferred cumulative dividends plus accretion (in shares)	7
Preferred cumulative dividends plus accretion	$ 13,502
Temporary equity, ending balance (in shares) at Mar. 31, 2024	439
Temporary equity, ending balance at Mar. 31, 2024	$ 364,762
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2023			151,242
Stockholders' equity, beginning balance at Dec. 31, 2023	259,248		$ 151	$ 344,517	$ (130,230)	$ 44,810
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)			460
Vesting of restricted stock units	0
Employee purchase plan (in shares)			25
Employee purchase plan	363			363
Equity-based compensation	3,914			3,914
Tax withholding related to vesting of equity-based compensation	(1,722)			(1,722)
Preferred cumulative dividends plus accretion	(13,502)			(13,502)
Net income	2,165				2,165
Foreign currency translation	(19,242)	[1]				(19,242)
Stockholders' equity, ending balance (in shares) at Mar. 31, 2024			151,727
Stockholders' equity, ending balance at Mar. 31, 2024	$ 231,224		$ 151	333,570	(128,065)	25,568
Temporary equity, beginning balance (in shares) at Dec. 31, 2024	460
Temporary equity, beginning balance at Dec. 31, 2024	$ 406,931
Increase (Decrease) in Temporary Equity [Roll Forward]
Preferred cumulative dividends plus accretion (in shares)	8
Preferred cumulative dividends plus accretion	$ 14,443
Temporary equity, ending balance (in shares) at Mar. 31, 2025	468
Temporary equity, ending balance at Mar. 31, 2025	$ 421,374
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2024			151,952
Stockholders' equity, beginning balance at Dec. 31, 2024	(118,096)		$ 151	297,780	(370,624)	(45,403)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)			518
Vesting of restricted stock units	0
Employee purchase plan (in shares)			43
Employee purchase plan	222			222
Equity-based compensation	2,798			2,798
Tax withholding related to vesting of equity-based compensation	(278)			(278)
Preferred cumulative dividends plus accretion	(14,443)			(14,443)
Net income	16,746				16,746
Foreign currency translation	15,277	[1]				15,277
Stockholders' equity, ending balance (in shares) at Mar. 31, 2025			152,513
Stockholders' equity, ending balance at Mar. 31, 2025	$ (97,774)		$ 151	$ 286,079	$ (353,878)	$ (30,126)

[1] There are no tax effects on foreign currency adjustments.